Thomas Kingsley Brown, Ph.D., started his research on ibogaine treatment in November of 2009 when he conducted interviews with patients at Pangea Biomedics (then in Playas de Tijuana, Mexico) and collected data to study changes in Quality of Life for those patients. Hearing about the transformative experiences of these people convinced him that ibogaine’s therapeutic value merited further study. Since 2010 he has been working with the Multidisciplinary Association of Psychedelic Studies (MAPS, based in Santa Cruz, California, USA) on a Mexico-based observational study of the long-term outcomes for people receiving ibogaine-assisted treatment for substance dependence. Of the 30 participants enrolled in that study, 25 were treated by Jeffrey Israel at his clinic near Rosarito, Baja California, Clare Wilkins treated Mexico, and five at Pangea Biomedics. That study is complete, and the first research article on the study has been submitted for publication. In 2013, Dr. Brown published a review article on ibogaine treatment in Current Drug Abuse Reviews. His academic background is primarily in chemistry (B.S., University of Pittsburgh and M.S., California Institute of Technology) and anthropology (Ph.D., UCSD). He has long had an interest in altered states of consciousness and life-changing experiences, such as religious conversion. He currently runs an undergraduate research program at the University of California, San Diego.